Instituto de Olhos de Goiania   Report issue

Academic/Hospital Phase 4
Founded: Goiânia Brazil (1976)

Organization Overview

First Clinical Trial
2005
NCT00564213
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Alternative names

Instituto de Olhos de GOiânia

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Choroidal Neovascularization (Phase 4)

Corneal Diseases (Phase 4)

Corneal Neovascularization (Phase 4)

Glaucoma (Phase 4)

Keratoconus (Phase 4)

Macular Degeneration (Phase 4)

Macular Edema (Phase 4)

Myopia (Phase 4)

Neovascularization, Pathologic (Phase 4)

Pterygium (Phase 3)

Retinal Diseases (Phase 4)

Retinal Neovascularization (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 12
  • # of Trial APIs: 5